Extrawell Pharmaceutical (HKG:0858) reported an attributable loss of HK$459.7 million for the fiscal first half, swinging from a profit of HK$100.9 million a year earlier, according to a Hong Kong bourse filing Friday.
Shares of the pharmaceutical company gained over 8% in morning trade Monday.
Loss per share for the half year ended Sept. 30 was HK$0.1909, compared with EPS of HK$0.0339 in the prior year.
Revenue fell to HK$28.0 million from HK$30.8 million last year, figures showed.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.